Brugada syndrome and syncope: A systematic review.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
12 2020
Historique:
received: 30 08 2020
revised: 25 09 2020
accepted: 05 10 2020
pubmed: 23 10 2020
medline: 29 7 2021
entrez: 22 10 2020
Statut: ppublish

Résumé

Distinguishing syncope due to malignant arrhythmias from an incidental benign form in Brugada syndrome (BrS) is often difficult. Through systematic literature review, we evaluated the role of syncope in predicting subsequent malignant arrhythmias in BrS. A comprehensive literature search was performed on PubMed (MeSH search terms "Brugada syndrome" and "syncope"). Overall, 9 studies for a total of 1347 patients were included. Patients were stratified as affected by suspected arrhythmic syncope (SAS), undefined syncope (US) or neurally-mediated syncope (NMS). Overall, 15.7% of the 279 patients with SAS had malignant arrhythmic events during a mean follow-up of 67 months, corresponding to 2.8 events per 100/person year. At the same time, 7% of the 527 patients affected by US had malignant arrhythmias during a mean follow-up of 39 months, corresponding 2.2 events per 100/person year. Conversely, 0.7% of 541 patients with NMS had malignant arrhythmic events at follow-up, corresponding to 0.13 events per 100/person year (p = .0001 NMS versus SAS and US pooled). In BrS population, the risk of arrhythmic events in the follow-up may be stratified according to the clinical evaluation. The "relatively" low predictive value of the clinical diagnosis of SAS warrants for a more accurate multi-parametric assessment, to restrict the number of candidates for implantable cardioverter-defibrillator therapy.

Identifiants

pubmed: 33090608
doi: 10.1111/jce.14787
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3334-3338

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Brignole M, Moya A, Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948.
Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry. Circulation. 2010;121:635-643.
Delise P, Allocca G, Marras E, et al. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J. 2011;32(2):169-176.
Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (programmed electrical stimulation predictive value) registry. J Am Coll Cardiol. 2012;59(1):37-45.
Sacher F, Arsac F, Wilton SB, et al. Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome. Heart Rhythm. 2012;9(8):1272-1279.
Takagi M, Aonuma K, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M. Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan. Heart Rhythm. 2013;10(4):533-539.
Olde Nordkamp LR, Vink AS, Wilde AA, et al. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes. Heart Rhythm. 2015;12(2):367-375.
Giustetto C, Cerrato N, Ruffino E, et al. Etiological diagnosis, prognostic significance and role of electrophysiological study in patients with Brugada ECG and syncope. Int J Cardiol. 2017;241:188-193.
Flórez JP, García D, Valverde I, et al. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing. Europace. 2018;20(FI1):f64-f71.
Hernandez-Ojeda J, Arbelo E, Jorda P, et al. The role of clinical assessment and electrophysiology study in Brugada syndrome patients with syncope. Am Heart J. 2020;220:213-223.

Auteurs

Giuseppe Mascia (G)

CardioThoracoVascular Department, Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Roberta Della Bona (R)

CardioThoracoVascular Department, Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Pietro Ameri (P)

CardioThoracoVascular Department, Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine, University of Genoa, Genoa, Italy.

Marco Canepa (M)

CardioThoracoVascular Department, Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine, University of Genoa, Genoa, Italy.

Italo Porto (I)

CardioThoracoVascular Department, Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine, University of Genoa, Genoa, Italy.

Michele Brignole (M)

Faint and Fall Program, Ospedale San Luca, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH